RECENT NEWS
January. 13, 2023
QureBio Q-1801 Project was approved by CDEDecember. 21, 2022
QureBio Ltd. to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI MeetingsOctober. 25, 2022
QureBio Q-1801 clinical trial application was accepted by NMPA
ABOUT
021-61622561（AM9:00-PM18:00）